✦ LIBER ✦

A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma

✍ Scribed by Bedikian, Agop Y.; Papadopoulos, Nicholas E.; Kim, Kevin B.; Hwu, Wen-Jen; Homsi, Jade; Glass, Michelle R.; Cain, Suzanne; Rudewicz, Patrick; Vernillet, Laurent; Hwu, Patrick

Book ID: 120882163
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 226 KB
Volume: 27
Category: Article
ISSN: 0735-7907
DOI: 10.1080/07357900802709159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7004 ORAL Phase II randomized, placebo c

7004 ORAL Phase II randomized, placebo controlled study of sorafenib in combination with dacarbazine in subjects with unresectable Stage III or Stage IV melanoma

✍ McDermott, D.; Sosman, J.A.; Hodi, F.S.; Gonzalez, R.; Linette, G.; Richards, J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

7003 ORAL Ipilimumab (MDX-010) in patien

7003 ORAL Ipilimumab (MDX-010) in patients with unresectable stage III or IV malignant melanoma: efficacy and safety data from a phase I trial

✍ Weber, J.; Hersh, E.; Yellin, M.; Nichol, G.; Urba, W.; Powderly, J.; O'Day, S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

9318 POSTER Phase 3 Randomized Study of

9318 POSTER Phase 3 Randomized Study of Ipilimumab (IPI) Plus Dacarbazine (DTIC) Vs DTIC Alone as First Line Treatment in Patients With Unresectable Stage III or IV Melanoma

✍ Robert, C.; Thomas, L.; Garbe, C.; Lebbe, C.; Baurain, J.F.; Testori, A.; Maio, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A randomized phase 2 study of temozolomi

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775

✍ Lisa A. Kottschade; Vera J. Suman; Domingo G. Perez; Robert R. McWilliams; Judit 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB